Halo Labs Provides Operational Update & Announces Closing of Promissory Note
Ryan Allway
January 31st, 2019
News
TORONTO–(BUSINESS WIRE)–
Halo Labs Inc. (“Halo” or the “Company“) (NEO:HALO, OTC:AGEEF) is pleased to provide an operational update given the recent developments at the Company in the past few months and announces the closing of a promissory note financing.
Halo’s CEO, Kiran Sidhu, stated: “As we start the new year off, I would like to provide our investors with an update on Halo as the end of 2018 was an incredibly busy time for the Company. In 2019, we expect to see the results of all that work come to fruition as the Company has transformed from a single state operator to a multi-state operator with California quickly become the driving force of the business. We are very excited with the outlook for 2019 and look forward to capitalizing on the opportunity ahead.”
OPERATIONS UPDATE
California
Halo successfully launched operations in its initial Cathedral City facility in late November 2018, commencing with the production of raw extracts and has now began to manufacture distillate in January. The initial facility is designed to be capable of producing 120,000 grams of distillate per week at full capacity and has commenced servicing the Company’s contract with Falcon International of 50,000 and 70,000 grams of distillate per week. The Company is in active discussion with a number of other customers for long term contracts. The Company has commenced planning of a second larger facility located in Cathedral City and anticipates production to commence at such facility in middle of 2019. The Company expects that the addition of this second Cathedral City facility will triple its production capacity in the state of California.
Nevada
The Company’s view is that the current supply of biomass remains limited in Nevada; however, Halo has identified locations for larger grow operations for its cultivation license and is exploring various opportunities. The Company is currently manufacturing its products on a limited basis and to date, Halo has penetrated 13 out of 65 dispensaries throughout Nevada with the sales team pushing to grow that number each week. We anticipate adding DabTabs™ to our Nevada menu in February which we expect will help increase dispensary penetration.
Oregon
The Company’s operations in Oregon have maintained steady monthly revenues. In November the Company introduced a line of edibles into the market which helped drive additional revenues. This month we introduced DabTabs™ that in the first two weeks have already stocked approximately 70 dispensaries in the state and we have already received re-orders. The Company has also begun to shift its product mix towards higher margin and more profitable products. The Oregon market continues to slowly improve as the number of competitors decrease.
Canada and International Markets
Halo signed its first international partnership in Lesotho, Africa with Bophelo Bioscience and Wellness Pty Ltd., one of the largest licensed land holders in the country. Halo will provide the operational expertise in exchange for an equity stake in the business in addition to a royalty and an off-take agreement for all of the extracted products. The Company has sent their master grower to begin planting the first plants to create extractable biomass. The Company is also in active discussions with a number of European and Canadian companies for similar partnerships and will update shareholders in the event that those discussions progress.
Technology
Halo is focused on being a leader in cannabis extraction utilizing proprietary science-based techniques and developing innovative products. The Company has entered in an exclusive distribution agreement with Ilo Vapor to launch the DabTab™ in California, Nevada, and Oregon. DabTabs™ are vaping technology that allows for the consumption of full spectrum concentrates with no mess. Halo expects to launch DabTabs™ in Oregon in January and California and Nevada in February. DabTabs™ have been favorably received and reviewed, including a feature in a leading mainstream technology publication Engadget. The Company is currently working on licensing deals for nano-emulsification technology for flavored drinks and shots. Lastly Halo is currently examining the use of biosynthesis technology for manufacturing of oils and concentrates which the Company believes could be a significant improvement over existing technologies in commercial use today.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer